Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
NCT ID: NCT01234701
Last Updated: 2012-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
108 participants
OBSERVATIONAL
2010-10-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploratory Study of MRI Biomarkers of NASH
NCT06626074
Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications
NCT01234714
MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)
NCT04227782
Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT
NCT02985034
Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging
NCT04705194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary liver tumors, non-cirrhotic
This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonance Imaging (MRI) and underwent resection for primary liver tumors.
Non-invasive Magnetic Resonance Imaging (MRI)
Conventional pre-operative MRI
Liver resection
Hepatectomy with an intention to cure
Histopathology diagnosis of resected liver specimen
Histopathology diagnosis by expert pathologist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-invasive Magnetic Resonance Imaging (MRI)
Conventional pre-operative MRI
Liver resection
Hepatectomy with an intention to cure
Histopathology diagnosis of resected liver specimen
Histopathology diagnosis by expert pathologist.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients that received a pre-operative Magnetic Resonance Imaging (MRI).
* Patients that underwent liver resection with an intention to cure.
* Patient over 18 years of age
Exclusion Criteria
* Patient age less than 18 years of age.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard University
OTHER
University Hospital, Essen
OTHER
Auckland City Hospital
OTHER_GOV
University Hospital, Strasbourg, France
OTHER
The Leeds Teaching Hospitals NHS Trust
OTHER
Imperial College London
OTHER
University College London Hospitals
OTHER
St. Louis University
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Breitenstein, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Zurich, Department of Visceral and Transplant Surgery, Zurich, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
St. Louis University, Liver Center
St Louis, Missouri, United States
University Hospital Strasbourg
Strasbourg, Cedex, France
University Hospital Essen
Essen, , Germany
Auckland City Hospital
Auckland, Auckland, New Zealand
University Hospital Zurich, Department of Interventional and Diagnostic Radiology
Zurich, Canton of Zurich, Switzerland
University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center
Zurich, Canton of Zurich, Switzerland
The Leeds Teaching Hospitals NHS Trust
Leeds, , United Kingdom
University College London Hospitals NHS Foundation Trust
London, , United Kingdom
Imperial College, Hammersmith Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Inter-rater reliability (also called: inter-rater agreement, or concordance) definitions and further information
Fleiss' kappa information
Cohen's kappa information
Intraclass correlation information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRI_Liver_Tumours_Evlauation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.